Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Joseph Biederman, M.D.

Co-Author

This page shows the publications co-authored by Joseph Biederman and Craig Surman.
Connection Strength

6.915
  1. L-Threonic Acid Magnesium Salt Supplementation in ADHD: An Open-Label Pilot Study. J Diet Suppl. 2021; 18(2):119-131.
    View in: PubMed
    Score: 0.888
  2. Does L-Methylfolate Supplement Methylphenidate Pharmacotherapy in Attention-Deficit/Hyperactivity Disorder?: Evidence of Lack of Benefit From a Double-Blind, Placebo-Controlled, Randomized Clinical Trial. J Clin Psychopharmacol. 2019 Jan/Feb; 39(1):28-38.
    View in: PubMed
    Score: 0.818
  3. A pilot open label prospective study of memantine monotherapy in adults with ADHD. World J Biol Psychiatry. 2013 May; 14(4):291-8.
    View in: PubMed
    Score: 0.511
  4. Representativeness of participants in a clinical trial for attention-deficit/hyperactivity disorder? Comparison with adults from a large observational study. J Clin Psychiatry. 2010 Dec; 71(12):1612-6.
    View in: PubMed
    Score: 0.457
  5. Atomoxetine in the treatment of adults with subthreshold and/or late onset attention-deficit hyperactivity disorder-not otherwise specified (ADHD-NOS): a prospective open-label 6-week study. CNS Neurosci Ther. 2010; 16(1):6-12.
    View in: PubMed
    Score: 0.438
  6. Association between attention-deficit/hyperactivity disorder and bulimia nervosa: analysis of 4 case-control studies. J Clin Psychiatry. 2006 Mar; 67(3):351-4.
    View in: PubMed
    Score: 0.336
  7. Adults with ADHD and sleep complaints: a pilot study identifying sleep-disordered breathing using polysomnography and sleep quality assessment. J Atten Disord. 2006 Feb; 9(3):550-5.
    View in: PubMed
    Score: 0.334
  8. Toward operationalizing deficient emotional self-regulation in newly referred adults with ADHD: A receiver operator characteristic curve analysis. Eur Psychiatry. 2020 02 24; 63(1):e21.
    View in: PubMed
    Score: 0.221
  9. A prospective open-label trial of long-acting liquid methylphenidate for the treatment of attention deficit/hyperactivity disorder in intellectually capable adults with autism spectrum disorder. World J Biol Psychiatry. 2020 04; 21(4):274-290.
    View in: PubMed
    Score: 0.219
  10. Memantine in the Treatment of Executive Function Deficits in Adults With ADHD. J Atten Disord. 2017 02; 21(4):343-352.
    View in: PubMed
    Score: 0.173
  11. Neuropsychological Deficits Are Not Predictive of Deficient Emotional Self-Regulation in Adults With ADHD. J Atten Disord. 2015 Dec; 19(12):1046-53.
    View in: PubMed
    Score: 0.137
  12. Understanding deficient emotional self-regulation in adults with attention deficit hyperactivity disorder: a controlled study. Atten Defic Hyperact Disord. 2013 Sep; 5(3):273-81.
    View in: PubMed
    Score: 0.136
  13. Atomoxetine increases fronto-parietal functional MRI activation in attention-deficit/hyperactivity disorder: a pilot study. Psychiatry Res. 2013 Jan 30; 211(1):88-91.
    View in: PubMed
    Score: 0.134
  14. Longitudinal course of deficient emotional self-regulation CBCL profile in youth with ADHD: prospective controlled study. Neuropsychiatr Dis Treat. 2012; 8:267-76.
    View in: PubMed
    Score: 0.130
  15. A controlled study of a simulated workplace laboratory for adults with attention deficit hyperactivity disorder. Psychiatry Res. 2012 Dec 30; 200(2-3):949-56.
    View in: PubMed
    Score: 0.129
  16. The effects of lisdexamfetamine dimesylate on driving behaviors in young adults with ADHD assessed with the Manchester driving behavior questionnaire. J Adolesc Health. 2012 Dec; 51(6):601-7.
    View in: PubMed
    Score: 0.129
  17. Severity of the aggression/anxiety-depression/attention child behavior checklist profile discriminates between different levels of deficits in emotional regulation in youth with attention-deficit hyperactivity disorder. J Dev Behav Pediatr. 2012 Apr; 33(3):236-43.
    View in: PubMed
    Score: 0.128
  18. The effects of lisdexamfetamine dimesylate on the driving performance of young adults with ADHD: a randomized, double-blind, placebo-controlled study using a validated driving simulator paradigm. J Psychiatr Res. 2012 Apr; 46(4):484-91.
    View in: PubMed
    Score: 0.126
  19. Toward defining deficient emotional self-regulation in children with attention-deficit/hyperactivity disorder using the Child Behavior Checklist: a controlled study. Postgrad Med. 2011 Sep; 123(5):50-9.
    View in: PubMed
    Score: 0.123
  20. Is response to OROS-methylphenidate treatment moderated by treatment with antidepressants or psychiatric comorbidity? A secondary analysis from a large randomized double blind study of adults with ADHD. CNS Neurosci Ther. 2012 Feb; 18(2):126-32.
    View in: PubMed
    Score: 0.122
  21. Deficient emotional self-regulation and adult attention deficit hyperactivity disorder: a family risk analysis. Am J Psychiatry. 2011 Jun; 168(6):617-23.
    View in: PubMed
    Score: 0.120
  22. A randomized, 3-phase, 34-week, double-blind, long-term efficacy study of osmotic-release oral system-methylphenidate in adults with attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 2010 Oct; 30(5):549-53.
    View in: PubMed
    Score: 0.115
  23. A randomized, single-blind, substitution study of OROS methylphenidate (Concerta) in ADHD adults receiving immediate release methylphenidate. J Atten Disord. 2011 May; 15(4):286-94.
    View in: PubMed
    Score: 0.113
  24. Association between attention-deficit/hyperactivity disorder and sleep impairment in adulthood: evidence from a large controlled study. J Clin Psychiatry. 2009 Nov; 70(11):1523-9.
    View in: PubMed
    Score: 0.106
  25. Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task. Arch Gen Psychiatry. 2008 Jan; 65(1):102-14.
    View in: PubMed
    Score: 0.095
  26. Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. BMC Psychiatry. 2007 Sep 14; 7:49.
    View in: PubMed
    Score: 0.093
  27. Are girls with ADHD at risk for eating disorders? Results from a controlled, five-year prospective study. J Dev Behav Pediatr. 2007 Aug; 28(4):302-7.
    View in: PubMed
    Score: 0.093
  28. A laboratory driving simulation for assessment of driving behavior in adults with ADHD: a controlled study. Ann Gen Psychiatry. 2007 Jan 30; 6:4.
    View in: PubMed
    Score: 0.089
  29. An open-label trial of OROS methylphenidate in adults with late-onset ADHD. CNS Spectr. 2006 May; 11(5):390-6.
    View in: PubMed
    Score: 0.085
  30. Characterizing impaired driving in adults with attention-deficit/hyperactivity disorder: A controlled study. J Clin Psychiatry. 2006 Apr; 67(4):567-74.
    View in: PubMed
    Score: 0.084
  31. A double-blind comparison of galantamine hydrogen bromide and placebo in adults with attention-deficit/hyperactivity disorder: a pilot study. J Clin Psychopharmacol. 2006 Apr; 26(2):163-6.
    View in: PubMed
    Score: 0.084
  32. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2006 May 01; 59(9):829-35.
    View in: PubMed
    Score: 0.083
  33. Is oppositional defiant disorder a meaningful diagnosis in adults? Results from a large sample of adults with ADHD. J Nerv Ment Dis. 2007 Jul; 195(7):601-5.
    View in: PubMed
    Score: 0.023
  34. Behavior differences in drivers with attention deficit hyperactivity disorder: the driving behavior questionnaire. Accid Anal Prev. 2005 Nov; 37(6):996-1004.
    View in: PubMed
    Score: 0.020
  35. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005 Mar 01; 57(5):456-63.
    View in: PubMed
    Score: 0.020
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.